• 1
    Ling W., Hillhouse M., Ang A., Jenkins J., Fahey J. Comparison of behavioral treatment conditions in buprenorphine maintenance. Addiction 2013; 108: 17881798.
  • 2
    Mattick R. P., Ali R., White J. M., O'Brien S., Wolk S., Danz C. Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patients. Addiction 2003; 98: 441452.
  • 3
    Strain E. C., Stitzer M. L., Liebson I. A., Bigelow G. E. Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index. J Clin Psychopharmacol 1996; 16: 5867.
  • 4
    Johnson R. E., Chutuape M. A., Strain E. C., Walsh S. L., Stitzer M. L., Bigelow G. E. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. N Engl J Med 2000; 343: 12901297.
  • 5
    Dutra L., Stathopoulou G., Basden S. L., Leyro T. M., Powers M. B., Otto M. W. A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry 2008; 165: 179187.
  • 6
    Carroll K. M., Rounsaville B. J., Gordon L. T., Nich C., Jatlow P., Bisighini R. M. et al. Psychotherapy and pharmacotherapy for ambulatory cocaine abusers. Arch Gen Psychiatry 1994; 51: 177187.
  • 7
    Carroll K. M., Nich C., Lapaglia D. M., Peters E. N., Easton C. J., Petry N. M. Combining cognitive behavioral therapy and contingency management to enhance their effects in treating cannabis dependence: less can be more, more or less. Addiction 2012; 107: 16501659.
  • 8
    Epstein D. H., Hawkins W. E., Covi L., Umbricht A., Preston K. L. Cognitive–behavioral therapy plus contingency management for cocaine use: findings during treatment and across 12-month follow-up. Psychol Addict Behav 2003; 17: 7382.
  • 9
    Rawson R. A., McCann M. J., Flammino F., Shoptaw S., Miotto K., Reiber C. et al. A comparison of contingency management and cognitive–behavioral approaches for stimulant-dependent individuals. Addiction 2006; 101: 267274.
  • 10
    Rawson R. A., Huber A., McCann M., Shoptaw S., Farabee D., Reiber C. et al. A comparison of contingency management and cognitive–behavioral approaches during methadone maintenance treatment for cocaine dependence. Arch Gen Psychiatry 2002; 59: 817824.
  • 11
    Lussier J. P., Heil S. H., Mongeon J. A., Badger G. J., Higgins S. T. A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction 2006; 101: 192203.
  • 12
    Prendergast M., Podus D., Finney J., Greenwell L., Roll J. Contingency management for treatment of substance use disorders: a meta-analysis. Addiction 2006; 101: 15461560.
  • 13
    Peirce J. M., Petry N. M., Stitzer M. L., Blaine J., Kellogg S., Satterfield F. et al. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study. Arch Gen Psychiatry 2006; 63: 201208.
  • 14
    Petry N. M., Martin B. Low-cost contingency management for treating cocaine- and opioid-abusing methadone patients. J Consult Clin Psychol 2002; 70: 398405.
  • 15
    Petry N. M., Martin B., Simcic F. Jr. Prize reinforcement contingency management for cocaine dependence: integration with group therapy in a methadone clinic. J Consult Clin Psychol 2005; 73: 354359.
  • 16
    Petry N. M., Alessi S. M., Hanson T., Sierra S. Randomized trial of contingent prizes versus vouchers in cocaine-using methadone patients. J Consult Clin Psychol 2007; 75: 983991.
  • 17
    Epstein D. H., Schmittner J., Umbricht A., Schroeder J. R., Moolchan E. T., Preston K. L. Promoting abstinence from cocaine and heroin with a methadone dose increase and a novel contingency. Drug Alcohol Depend 2009; 101: 92100.